Articles Published in 2009

Datatrak Delisted from NASDAQ

Wednesday, June 10, 2009 07:30 AM

Datatrak, a Cleveland-based  eClinical company, was delisted from the stock exchange after failing to meet NASDAQ's $2.5-million minimum stockholders' equity requirement.

More... »

Clinical Trials in Russia: SynRG Orange Paper Q1

Tuesday, June 9, 2009 07:31 AM

On June 1, 2009, Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Q1 2009, a regular analytical report on the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables covering various aspects of the Russian clinical trial market.

More... »

MDS Pharma to Focus on Early Stage, Selling Late Stage to INC Research for $50M

Monday, June 8, 2009 08:49 AM

MDS, the parent company of MDS Pharma Services, has entered into an agreement with INC Research to sell off MDS' phase II through IV contract research business for $50 million in order to focus on early-stage clinical development.

More... »

CenterWatch Monthly June 2009

Friday, June 5, 2009 09:17 AM

U.S. Sites Rate Medpace, Kendle, ICON as Top CROs in 2009

More... »

AAHRPP's Revised Standards Available for Comment

Thursday, June 4, 2009 07:13 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) released revised accreditation standards June 1--the first major revision since the organization established the standards in 2001.

More... »

Etrials Pays $500K to Terminate Agreement with BioClinica

Wednesday, June 3, 2009 07:00 AM

Only days after BioClinica increased its purchase offer to acquire etrials Worldwide and the two companies agreed to proceed with their acquisition agreement, that agreement has been terminated.

More... »

INC Research Plans to Acquire Late Stage Division of MDS for $50M

Tuesday, June 2, 2009 07:00 AM

Raleigh, N.C.-based contract research organization (CRO) INC Research entered into an agreement to acquire the phase II through IV operations of MDS Pharma Services, the clinical development division of MDS, for $50 million.

More... »

Palm Beach CRO Plans Growth in U.S and Beyond

Monday, June 1, 2009 07:00 AM

Palm Beach CRO in West Palm Beach, Fla., may be a new player in the clinical trial industry, but its founders and leadership are not.

More... »

Guest Commentary: Quality in Clinical Research --- An Indian Perspective

Thursday, May 28, 2009 09:27 AM

At a recent ACRP chapter meeting in India, industry leaders participated in a panel discussion on quality in clinical research in India. The panelists included: Larisa Nagra Singh, senior director, Asia Pacific ,ICON; Dr. Sacchidananda, dermatologist, registrar evaluation, Rajiv Gandhi University of Health Sciences, Bangalore; Suresh Ramu, vice president, Quintiles; Mitesh Patel, head, CTL Services,  Quintiles India and director, clinical operations, Bangalore; and Dr. Anil Shinde, clinical operations,  director, NovoNordisk. The discussion was moderated by Dr. Raman Shetty, director clinical research, Allergan, India. The following is an excerpt from that discussion prepared by Dr. Shetty of Allergan and Pratibha Nadig, M.D.; Medha Joshi, M.D.; and Santosh Hegde (all of the Bilcare Research Academy, Bangalore, India) .

More... »

Nextrials Sees Latest Trial as the Future of EDC

Wednesday, May 27, 2009 06:57 AM

Electronic data capture (EDC) company Nextrials is conducting a multisite trial that CEO James Rogers views as the future of clinical trials and possibly of his company.

More... »